Biocon Limited (BIOCON) Share Price & AI Investment Analysis

Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics; Biosimilars; and Contract Research, Development and Manufacturing Organization (CRDMO) segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, central nervous system, anti-cancer/oncology, multiple sclerosis, immunosuppressants, and specialty molecules; and biosimilars products for oncology, diabetes, and. Track Biocon Limited's live NSE:BIOCON share price ₹387.00 (-2.03%), market cap ₹₹630B, P/E 112.5. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for BIOCON — real-time NSE India stock intelligence.